Back to results
US 5,965,721 AGranted
Backbone modified oligonucleotide analogues
AssigneeIsis Pharmaceuticals, Inc.
InventorsPhillip Dan Cook, Yogesh Shantilal Sanghvi, Jean Jacques Vasseur, Francoise Debart
Life of this patent
Estimating the term…
Abstract
Therapeutic oligonucleotide analogues which have improved nuclease resistance and improved cellular uptake are provided. Replacement of the normal phosphorodiester inter-sugar linkages found in natural oligomers with four atom linking groups forms unique di- and poly-nucleosides and nucleotides useful in regulating RNA expression and in therapeutics. Methods of synthesis and use are also disclosed.
Claims11
An oligonucleotide analogue in which at least one of the subunits of the analogue have the structure:
- ##STR9## wherein B.sub.x is a variable base;
- Q is O;
- X is C.sub.1 to C.sub.10 lower alkyl, substituted lower alkyl, alkaryl or aralkyl;
- F;
- Cl;
- Br;
- CN;
- CF.sub.3 ;
- OCF.sub.3 ;
- OCN;
- O--, S--, or N-alkyl;
- O--, S--, or N-alkenyl;
- SOCH.sub.3 ;
- SO.sub.2 CH.sub.3 ;
- ONO.sub.2 ;
- NO.sub.2 ;
- N.sub.3 ;
- NH.sub.2 ;
- heterocycloalkyl;
- heterocycloalkaryl;
- aminoalkylamino;
- polyalkylamino;
- or substituted silyl;
- L.sub.1 is CH.sub.2 ;
- L.sub.2 is P(O)R.sub.4 ;
- L.sub.3 is O;
- L.sub.4 is CH.sub.2 ;
- R.sub.4 is OH, SH, NH.sub.2, O-alkyl, S-alkyl, NH-alkyl, O-alkylheterocyclo, S-alkylheterocyclo, N-alkylheterocyclo or a nitrogen-containing heterocycle.
25 more elements
Dependencies are inferred from the claim text.